Plasma Aβ42/Aβ40 and p-tau181 Predict Long-Term Clinical Progression in a Cohort with Amnestic Mild Cognitive ImpairmentZhenxu Xiao, Qianhua Zhao, Jiaying Lu et al.|Clinical Chemistry|2022Cited by 32
Plasma Aβ42/Aβ40 and p‐tau181 are associated with clinical progression in amnestic mild cognitive impairment: An 8‐year longitudinal studyZhenxu Xiao, Ding Ding, Wanqing Wu et al.|Alzheimer s & Dementia|2023Cited by 0